Is Macrobid (Nitrofurantoin) safe to use during the 1st trimester of pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Macrobid (Nitrofurantoin) Safety in First Trimester

Nitrofurantoin can be used during the first trimester of pregnancy when no other suitable alternative antibiotics are available, though it should be reserved for appropriate indications and used for the shortest effective duration. 1, 2

Primary Recommendation

The American College of Obstetricians and Gynecologists (ACOG) states that prescribing nitrofurantoin in the first trimester is still considered appropriate when no other suitable alternative antibiotics are available. 1, 2 This represents a nuanced position acknowledging both theoretical concerns and practical clinical needs.

Evidence Quality and Safety Profile

  • The evidence regarding nitrofurantoin and birth defects is mixed, with no definitive causal relationship established. 1, 2

  • A retrospective analysis of 91 pregnancies in 81 women treated with nitrofurantoin macrocrystals during pregnancy found no evidence of fetal toxicity, with no abnormal events considered drug-related. 3

  • The incidence of fetal death, neonatal death, malformations, prematurity, low birth weight, low Apgar scores, and jaundice was not significantly different from the general U.S. population. 3

  • Existing data indicate that exposure to nitrofurantoin during pregnancy is not associated with increased risk of fetal malformations. 4

Clinical Decision Algorithm

When treating urinary tract infections in the first trimester:

  1. First-line alternatives to consider first:

    • Penicillins (amoxicillin) are safe throughout pregnancy including first trimester 4
    • Cephalosporins (cephalexin) are safe throughout pregnancy 5, 4
  2. Use nitrofurantoin when:

    • The organism is resistant to first-line agents 1, 2
    • Patient has documented allergies to penicillins/cephalosporins 1, 2
    • Other suitable alternatives are not available 1, 2
  3. Prescribing principles:

    • Use only for appropriate indications 1, 2
    • Prescribe for the shortest effective duration 1, 2
    • Do not deny treatment—untreated infections commonly lead to serious maternal and fetal complications 1, 2

Critical Context: Risk-Benefit Balance

The most important clinical principle: pregnant women should not be denied appropriate treatment for infections. 1, 2 Untreated urinary tract infections during pregnancy pose increased risk to both mother and fetus, including progression to acute pyelonephritis. 6

Second and Third Trimester Guidance

  • During the second and third trimesters, nitrofurantoin may be used as a first-line agent for treatment and prevention of urinary tract infections. 1, 2

  • Nitrofurantoin has proven highly effective for prophylaxis of recurrent UTIs during pregnancy, with one study showing reduction from 130 UTIs pre-prophylaxis to only 1 UTI during pregnancy with postcoital prophylaxis (50 mg dose). 6

Common Pitfall to Avoid

Do not withhold necessary antibiotic treatment in the first trimester due to theoretical concerns when the infection itself poses documented risks to pregnancy outcomes. The evidence does not support an absolute contraindication, and untreated infections carry known serious complications. 1, 2

References

Research

Urinary tract infections in pregnancy.

Canadian family physician Medecin de famille canadien, 2008

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Effective prophylaxis for recurrent urinary tract infections during pregnancy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.